Study Objective: To evaluate the effects on efficacy and safety of a formulary change from granulocyte colony-stimulating factor (G-CSF) to granulocyte-macrophage CSF (GM-CSF).
Design: Retrospective chart review.
Setting: Single-center academic institution.